← Insider buys

SSKN

STRATA Skin Sciences, Inc. · Healthcare

No insider bought or sold STRATA Skin Sciences, Inc. in the last 12 months

$0Bought, 12 mo
$0Sold, 12 mo
$1KMarket cap

SSKN over the last year

No insider buys filed in this year

SSKN after insider buys

3 months after each buy, from the first price a copier could get.

−25.4%Average
−22.6 ptsVs S&P 500
0 of 6Higher

6 buys since 2018 with 3 months of prices.

Every filing

12 insider filings since 2016, newest first

About STRATA Skin Sciences, Inc.

STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, China, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. It operates through Dermatology Recurring Procedures and Dermatology Procedures Equipment segments. The company offers XTRAC excimer laser and VTRAC lamp systems, which are used in the treatment of psoriasis, vitiligo, atopic dermatitis, and leukoderma; and TheraClear acne therapy system for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. It serves dermatologists and dermatological group clinics. The company was formerly known as MELA Sciences, Inc. and changed its name to STRATA Skin Sciences, Inc. in December 2015. STRATA Skin Sciences, Inc. was incorporated in 1989 and is headquartered in Horsham, Pennsylvania.

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.